Mineralocorticoid receptor antagonism of dihydropyridine Ca channel blocker.

Mineralocorticoid receptor antagonism of dihydropyridine Ca channel blocker. - MR antagonism of CCB

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000025450

Enrollment

100

Registered

2016-12-28

Start date

2017-01-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary aldosteronism

Interventions

nifidipine diltiazem

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: primary aldosteronism

Exclusion criteria

Exclusion criteria: renal failure (anuria)

Design outcomes

Primary

Measure	Time frame
blockade against mineralocorticoid activity in kidney	—

Countries

Japan

Contacts

Public ContactIsao Kurihara

Keio university school of medicine Endocrinology, metabolism and nephrology

i-kuri@dc4.so-net.ne.jp03-5363-3796

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026